Status
Conditions
Treatments
About
The study design is a prospective, multi-center, single-arm, non-randomized, and noncontrolled post market clinical follow-up study involving orthopedic surgeons skilled in arthroscopic rotator cuff repair as determined by the Sponsor.
Full description
The objectives of the study are to calculate the overall clinical success rate, the performance, and clinical benefits, and confirm the safety of the Tapestry RC Biointegrative Implant System.
The primary endpoint of this study is defined by the rotator cuff re-tear rate post-operatively. This will be measured against the success criteria of the re-tear rate in 18.3% of cases at two years.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Adult, 21 years and older;
Patient with a diagnosis of a symptomatic primary partial-thickness or full-thickness tear of the supraspinatus and/or infraspinatus tendons amenable to repair that meets one of the following criteria:
Patient is able and willing to complete the protocol required follow-up;
Patient is able and willing to sign the IRB approved informed consent;
Independent of study participation, patient qualifies for arthroscopic rotator cuff repair and meets the approved indications for use of the commercially available Tapestry RC Biointegrative Implant System
Exclusion criteria
170 participants in 2 patient groups
Loading...
Central trial contact
Jarrod Hunnicutt; Linda Anumele
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal